Getting the biggest bang for the regulatory buck doesn't mean that the FDA needs fewer bucks.
According to a story on today’s AP wire:
“House Republicans are seeking to keep their campaign promise to cut $100 billion from domestic programs … The hardest hit agencies would include the Food and Drug Administration …”
This is a crucial debate at a time when the agency needs more, not less funding and PDUFA is up for reauthorization. Both the Congressional determination to spend more wisely and the pharmaceutical industry’s desire that PDUFA V returns to first principles are not mutually exclusive. What both groups want is a properly funded FDA that spends its money in a responsible and predictable manner.
For more on the urgent need for smart and timely PDUFA reauthorization, see here, here, here, and here.
“Money is better than poverty, if only for financial reasons”
-- Woody Allen
Getting the Biggest Bang for the Regulatory Buck
Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.
